NEWS and OPINIONS

Top FDA Gene and Cell Therapy News: 2025 Year-End Recap

Top FDA Gene and Cell Therapy News: 2025 Year-End Recap

By Matt Hoffman - CGTlive - As 2025 comes to a close, CGTLive has looked back on some of the most-read and most impactful FDA regulatory decisions and news in the cell and gene therapy space. These approvals and regulatory actions marked major progress for patients...

read more
New method preserves iPS cells for regenerative medicine

New method preserves iPS cells for regenerative medicine

By Drug Target Review - Kobe University researchers have developed a new way of freeze induced pluripotent stem cells (iPS cells) directly in their culture dishes without losing viability or pluripotency. Researchers at Kobe University have developed a novel method...

read more
Interviews of 2025: The Big Issues

Interviews of 2025: The Big Issues

By Danny Sullivan - Longevity.Technology - Healthspan as a universal right, the need for new regulation, the age of mitochondrial therapies and 7 shifts to accelerate longevity. As we reflect on some of the interviews we’ve conducted over the past 12 months, it’s...

read more
Novel surgical approach for retinal gene therapy shows promise

Novel surgical approach for retinal gene therapy shows promise

By Mayo Clinic - A Mayo Clinic study published in the September 2025 issue of Science Advances explores a novel approach to retinal gene therapy using fibrin hydrogels encapsulating adeno-associated virus 2-green fluorescent protein (AAV2-GFP). The findings suggest a...

read more